Ausgabe 9/2025
Inhalt (13 Artikel)
Clinical Pharmacokinetics and Pharmacodynamics of Remimazolam
- Open Access
- Review Article
Bas T. de Jong, Douglas J. Eleveld, Keira P. Mason, Michel M. R. F. Struys
Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective
- Open Access
- Review Article
Nokwanda N. Ngcobo
Methodological Techniques Used in Machine Learning to Support Individualized Drug Dosing Regimens Based on Pharmacokinetic Data: A Scoping Review
- Systematic Review
Janthima Methaneethorn, Khanita Duangchaemkarn, Brad Reisfeld, Sohaib Habiballah
Pharmacokinetics of Sufentanil After Epidural Administration During the Course of Extensive Abdominal Surgery
- Open Access
- Original Research Article
Agnieszka Bienert, Agnieszka Borsuk-De Moor, Paulina Okuńska, Justyna Ber, Danuta Siluk, Małgorzata Waszczuk, Krzysztof Kusza, Tomasz Bartkowiak, Jakub Szrama, Anna Kluzik, Tomasz Koszel, Paweł Wiczling
Population Pharmacokinetics and Pharmacodynamics Modeling for the Use of Recaticimab in Healthy Volunteers and Patients with Hypercholesterolemia
- Original Research Article
Chang Shu, Ying Wang, Sheng Feng, Shengxian Yang, Kai Shen
A Novel Approach to Evaluating the Design of Pediatric Pharmacokinetic Studies Focused on Accurate Dose Selection
- Open Access
- Original Research Article
Yuanxi Zou, Jerry Nedelman, Mats O. Karlsson, Elin M. Svensson
Effect of Efsubaglutide Alfa on the Pharmacokinetics of Metformin and Digoxin in Healthy Participants
- Original Research Article
Xiaojie Wu, Jinjie He, Junzhen Wu, Wei Liu, Yulong Xu, Yiming Li, Jing Zhang, Qinghua Wang
A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients
- Open Access
- Original Research Article
Marith I. Francke, Sebastiaan D. T. Sassen, Nuria Lloberas, Helena Colom, Laure Elens, Serge Moudio, Aiko P. J. de Vries, Dirk Jan A. R. Moes, Ron H. N. van Schaik, Dennis A. Hesselink, Brenda C. M. de Winter
Population Pharmacokinetic and Pharmacodynamic Modelling and Simulation for Nedosiran Clinical Development and Dose Guidance in Pediatric Patients with Primary Hyperoxaluria Type 1
- Open Access
- Original Research Article
Steven Zhang, Pablo Gamallo, Verity Rawson
Revisiting Acyclovir Dosing for Adult Viral Encephalitis Using a Full Bayesian LeiCNS PBPK Modeling Approach
- Open Access
- Original Research Article
Ming Sun, Martijn L. Manson, Anne-Grete Märtson, Jacob Bodilsen, Elizabeth C. M. de Lange, Tingjie Guo
Comment on “Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights”
- Letter to the Editor
Nuala A. Helsby, Jacqueline A. Hannam
Author’s Reply to Helsby and Hannam: ‘Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights’
- Open Access
- Letter to the Editor
Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, Linda B. S. Aulin, Amrei-Pauline Konrad, Franziska Kluwe, Gerd Mikus, Wilhelm Huisinga, Charlotte Kloft, Robin Michelet
Correction: Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten
- Open Access
- Correction
Donghong Xu, Justin D. Lutz, Punag Divanji, Jianlin Li, Youcef Benattia, Adrienne Griffith, Stephen B. Heitner, Stuart Kupfer, Polina German
